Relay Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLAY and other ETFs, options, and stocks.

About RLAY

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. 

CEO
Sanjiv K. Patel
CEOSanjiv K. Patel
Employees
245
Employees245
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
245
Employees245

RLAY Key Statistics

Market cap
1.99B
Market cap1.99B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
831.60K
Average volume831.60K
High today
$17.41
High today$17.41
Low today
$16.38
Low today$16.38
Open price
$17.29
Open price$17.29
Volume
561.20K
Volume561.20K
52 Week high
$35.36
52 Week high$35.36
52 Week low
$12.65
52 Week low$12.65

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
9.1%
Sell
9.1%

RLAY Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.